Combating Bioequivalence Data Fraud: Indian CROs Face Mandatory Registration

Indian CROs Will Need To Register Their Business From 1 April

As Indian CROs are bracing for new registration mandates, an expert panel at the IGBA’s 3rd Bioequivalence conference discusses the implications of non-compliance in bioequivalence studies.

Domino, Impact, Continuity.
Compliance issues at one CRO can have a knock-on effect on multiple applications (Shutterstock)

Contract research organizations based in India will be facing mandatory registration from 1 April in a bid to improve the country’s clinical research industry.

More from Clinical Trials

More from Geography